FDA Grants Approval for Dapsone ANDA218335 by Macleods Pharmaceuticals
The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 218335 for Dapsone submitted by Macleods Pharmaceuticals.
Therapeutic Area
Therapeutic area intelligence for Antimicrobial with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
The FDA has approved ANDA213414 for Dapsone submitted by Alembic.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.